For instance, mutations in oncogene epithelial cell transforming sequence 2 (ECT2) were strongly associated with advanced CRCs, even more than serum CEA levels (Wang H. et al., 2019), supporting its usefulness in the prognosis of CRC (Chen et al., 2017) (Table 1). The gene discussed is CEACAM5; the disease is colorectal carcinoma.